Last Close
Mar 31  •  04:00PM ET
26.04
Dollar change
+1.98
Percentage change
8.23
%
Index- P/E- EPS (ttm)-1.63 Insider Own0.01% Shs Outstand33.94M Perf Week12.00%
Market Cap883.80M Forward P/E- EPS next Y-0.15 Insider Trans- Shs Float33.93M Perf Month-48.40%
Enterprise Value822.43M PEG- EPS next Q-0.32 Inst Own10.67% Short Float1.80% Perf Quarter-28.58%
Income-53.95M P/S- EPS this Y-568.75% Inst Trans27.10% Short Ratio2.56 Perf Half Y-49.31%
Sales0.00M P/B8.09 EPS next Y81.62% ROA-44.04% Short Interest0.61M Perf YTD-28.04%
Book/sh3.22 P/C13.43 EPS next 5Y- ROE-50.48% 52W High61.45 -57.62% Perf Year44.75%
Cash/sh1.94 P/FCF- EPS past 3/5Y9.31% -49.42% ROIC-48.36% 52W Low12.27 112.14% Perf 3Y408.52%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility7.48% 8.57% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-48.46% Oper. Margin- ATR (14)2.99 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.00 Sales Y/Y TTM- Profit Margin- RSI (14)35.98 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio4.03 EPS Q/Q-73.26% SMA20-21.98% Beta1.50 Target Price54.33
Payout- Debt/Eq0.04 Sales Q/Q- SMA50-37.95% Rel Volume1.59 Prev Close24.06
Employees- LT Debt/Eq0.03 EarningsMar 12 BMO SMA200-35.48% Avg Volume238.76K Price26.04
IPOJun 21, 2022 Option/ShortYes / Yes EPS/Sales Surpr.350.00% -100.00% Trades Volume379,552 Change8.23%
Date Action Analyst Rating Change Price Target Change
Mar-27-26Initiated BTIG Research Buy $40
Jan-13-26Initiated William Blair Outperform
Aug-20-25Initiated Roth Capital Buy $64
Oct-10-24Initiated B. Riley Securities Buy $30
Mar-30-26 09:51AM
Mar-18-26 08:00AM
Mar-16-26 11:30AM
Mar-13-26 10:50AM
Mar-05-26 12:01AM
09:40AM Loading…
Mar-04-26 09:40AM
Feb-27-26 05:00AM
Feb-02-26 09:55AM
08:30AM
Jan-30-26 08:30AM
Jan-27-26 07:57AM
Jan-25-26 06:50PM
Jan-23-26 09:40AM
Jan-22-26 08:30AM
Jan-16-26 08:30AM
08:30AM Loading…
Dec-15-25 08:30AM
Nov-17-25 08:30AM
Oct-30-25 08:30AM
Sep-27-25 08:40AM
Sep-26-25 08:30AM
Sep-09-25 01:02AM
Sep-02-25 08:30AM
Aug-26-25 08:30AM
Aug-07-25 08:30AM
Jul-25-25 09:40AM
Jul-23-25 08:30AM
Jul-14-25 12:54PM
Jun-11-25 08:30AM
Jun-10-25 07:30AM
Jun-05-25 08:30AM
12:50PM Loading…
May-05-25 12:50PM
Apr-15-25 08:30AM
Apr-08-25 08:30AM
Apr-01-25 08:30AM
Mar-13-25 08:30AM
Mar-11-25 08:30AM
Feb-18-25 08:30AM
Feb-06-25 08:30AM
Jan-28-25 08:30AM
Nov-26-24 08:30AM
Aug-14-24 08:30AM
Jul-02-24 12:00PM
May-01-24 08:30AM
Apr-26-24 08:30AM
Apr-15-24 08:30AM
Feb-14-24 08:30AM
Jan-16-24 08:30AM
Nov-29-23 09:00AM
Nov-08-23 08:30AM
Nov-01-23 08:30AM
Oct-19-23 08:30AM
Oct-09-23 08:30AM
Oct-02-23 08:30AM
Sep-07-23 08:30AM
Sep-06-23 08:30AM
Aug-28-23 08:30AM
Aug-23-23 08:30AM
Aug-17-23 08:30AM
Aug-15-23 08:30AM
Jul-31-23 08:30AM
Jul-10-23 08:30AM
Jun-15-23 08:00AM
Jun-13-23 08:00AM
Apr-27-23 08:30AM
Apr-26-23 08:30AM
Apr-20-23 08:30AM
Mar-28-23 08:00AM
IperionX Ltd. engages in the development of low carbon titanium for advanced industries, including space, aerospace, electric vehicles and 3D printing. It produces titanium metal powders from titanium scrap at its operational pilot facility in Utah and intends to scale production at a Titanium Demonstration Facility in Virginia. The company was founded by Anastasios Arima and Scott Sparks on May 5, 2017 and is headquartered in Charlotte, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Symonds Toby EdgcumbePresidentMar 27 '26Buy23.8711,000262,55211,000Mar 30 09:23 AM
Tripeny R TonyDirectorMar 27 '26Buy23.764,18799,4644,187Mar 30 09:08 AM
Hannigan ToddDirectorMar 27 '26Buy3.20225,225720,92325,628,334Mar 30 08:57 AM
Arima AnastasiosChief Executive OfficerMar 27 '26Buy3.74479,8001,793,11012,206,782Mar 30 08:38 AM
Last Close
Mar 31  •  04:00PM ET
88.42
Dollar change
+3.35
Percentage change
3.94
%
MLAB Mesa Laboratories, Inc daily Stock Chart
IndexRUT P/E136.96 EPS (ttm)0.65 Insider Own3.12% Shs Outstand5.52M Perf Week8.99%
Market Cap488.50M Forward P/E10.38 EPS next Y8.52 Insider Trans3.68% Shs Float5.35M Perf Month-5.17%
Enterprise Value629.54M PEG- EPS next Q2.08 Inst Own90.06% Short Float4.20% Perf Quarter10.55%
Income3.73M P/S1.97 EPS this Y-13.42% Inst Trans-7.49% Short Ratio2.04 Perf Half Y38.01%
Sales247.54M P/B2.62 EPS next Y-6.07% ROA0.86% Short Interest0.22M Perf YTD12.64%
Book/sh33.79 P/C16.86 EPS next 5Y- ROE2.18% 52W High131.20 -32.61% Perf Year-25.48%
Cash/sh5.25 P/FCF12.88 EPS past 3/5Y- - ROIC1.07% 52W Low55.45 59.46% Perf 3Y-49.40%
Dividend Est.- EV/EBITDA14.90 Sales past 3/5Y9.34% 15.41% Gross Margin54.69% Volatility3.15% 5.21% Perf 5Y-63.69%
Dividend TTM0.64 (0.72%) EV/Sales2.54 EPS Y/Y TTM101.44% Oper. Margin6.96% ATR (14)4.11 Perf 10Y-8.23%
Dividend Ex-DateFeb 27, 2026 Quick Ratio1.45 Sales Y/Y TTM4.12% Profit Margin1.51% RSI (14)56.42 Recom2.33
Dividend Gr. 3/5Y0.00% 0.00% Current Ratio1.94 EPS Q/Q311.31% SMA207.00% Beta0.91 Target Price104.50
Payout- Debt/Eq0.91 Sales Q/Q3.64% SMA502.43% Rel Volume0.90 Prev Close85.07
Employees730 LT Debt/Eq0.86 EarningsFeb 03 BMO SMA20012.00% Avg Volume109.97K Price88.42
IPOFeb 29, 1984 Option/ShortNo / Yes EPS/Sales Surpr.119.29% 2.99% Trades Volume99,266 Change3.94%
Date Action Analyst Rating Change Price Target Change
Aug-07-25Upgrade Wells Fargo Underweight → Equal Weight $67
Aug-28-24Initiated Wells Fargo Underweight $120
Jan-04-24Upgrade Evercore ISI In-line → Outperform $100 → $125
Jan-04-21Downgrade Evercore ISI Outperform → In-line $300
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $287
Oct-02-20Initiated JP Morgan Neutral $260
Dec-04-19Initiated Jefferies Buy
Aug-26-19Initiated Evercore ISI Outperform $250
Jun-10-16Downgrade Sidoti Buy → Neutral
Mar-09-26 04:30PM
Feb-20-26 07:02AM
Feb-03-26 08:11AM
08:00AM
Jan-07-26 05:00PM
07:00PM Loading…
Dec-18-25 07:00PM
Dec-03-25 05:35PM
Nov-25-25 08:09AM
Nov-12-25 03:14PM
Nov-06-25 07:01PM
04:15PM
Oct-03-25 11:46AM
11:01AM
Sep-22-25 06:53AM
Sep-05-25 06:34PM
02:01PM Loading…
Aug-18-25 02:01PM
Aug-05-25 09:15AM
08:10AM
08:00AM
Jul-31-25 05:45PM
Jul-03-25 12:00PM
Jul-02-25 03:20PM
May-28-25 09:15AM
08:23AM
08:00AM
May-15-25 05:25PM
May-14-25 05:45PM
May-13-25 05:35PM
May-08-25 08:45AM
Apr-07-25 03:00PM
03:51PM Loading…
Apr-03-25 03:51PM
Mar-26-25 12:00PM
Feb-13-25 08:31AM
Feb-11-25 12:20PM
Feb-04-25 09:15AM
08:17AM
08:00AM
Jan-17-25 01:15PM
Jan-06-25 03:00PM
Nov-07-24 09:20AM
08:27AM
08:00AM
Oct-15-24 05:02PM
Oct-02-24 02:00PM
Aug-26-24 12:20PM
12:00PM
Aug-16-24 07:51AM
Aug-05-24 08:15AM
08:00AM
Jul-31-24 09:14AM
Jul-08-24 02:00PM
Jun-05-24 11:53AM
06:38AM
06:21AM
06:00AM
May-31-24 06:00AM
May-22-24 06:00AM
Apr-08-24 08:00AM
Apr-04-24 06:24PM
Apr-01-24 10:27AM
Mar-15-24 07:00AM
Feb-19-24 10:23AM
Feb-05-24 09:20AM
08:36AM
08:22AM
08:00AM
Jan-08-24 08:00AM
Jan-04-24 03:00PM
Jan-03-24 08:00AM
Dec-14-23 10:47AM
Nov-06-23 09:10AM
08:13AM
08:00AM
Oct-16-23 03:00AM
Oct-03-23 08:00AM
Sep-22-23 08:09AM
06:20AM
Sep-15-23 01:10AM
Sep-13-23 01:37PM
Sep-11-23 11:21AM
Aug-24-23 04:02PM
Aug-10-23 01:32AM
Aug-03-23 09:35AM
08:27AM
08:00AM
Jul-31-23 07:50AM
Jul-05-23 03:00PM
Jun-21-23 08:00PM
11:50AM
May-25-23 09:25AM
08:14AM
08:00AM
May-22-23 01:16PM
May-02-23 06:23AM
Apr-26-23 08:00PM
Apr-03-23 06:15PM
06:00PM
07:42AM
Mar-13-23 08:00AM
Mar-09-23 08:00AM
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ladiwala Shiraz ShabanaliDirectorMar 10 '26Buy72.233,500252,8058,523Mar 10 05:43 PM
Capone Mark ChristopherDirectorMar 10 '26Buy76.351,30199,3313,429Mar 10 03:46 PM
Tripeny R TonyDirectorMar 10 '26Buy76.001,31599,9405,398Mar 10 03:39 PM
Owens Gary MPresident and CEOOct 27 '25Option Exercise0.0011,558064,135Oct 28 03:08 PM
Ladiwala Shiraz ShabanaliDirectorAug 15 '25Option Exercise0.001,94905,023Aug 18 02:37 PM
Sullivan John JamesDirectorAug 15 '25Option Exercise0.001,404027,282Aug 18 02:20 PM
Hall ShannonDirectorAug 15 '25Option Exercise0.001,40404,189Aug 18 02:02 PM
Tripeny R TonyDirectorAug 15 '25Option Exercise0.001,40404,083Aug 18 01:54 PM
Capone Mark ChristopherDirectorAug 15 '25Option Exercise0.001,40402,128Aug 18 01:45 PM
Alltoft Jennifer SadieDirectorAug 15 '25Option Exercise0.001,40404,878Aug 18 01:34 PM
Sakys JohnCFOJun 21 '25Option Exercise95.821,03699,27015,498Jun 25 09:14 AM
Archbold Brian DavidSVP OperationsJun 21 '25Option Exercise95.8284480,8722,792Jun 25 09:05 AM
Owens Gary MPresident and CEOJun 21 '25Option Exercise95.823,301316,30254,022Jun 24 10:12 AM
Owens Gary MPresident and CEOJun 18 '25Option Exercise92.998,707809,66454,531Jun 20 05:39 PM
Archbold Brian DavidSVP OperationsJun 18 '25Option Exercise92.992,556237,6823,114Jun 20 05:31 PM
Sakys JohnCFOJun 18 '25Option Exercise92.992,840264,09215,705Jun 20 05:22 PM
Owens Gary MPresident and CEOJun 15 '25Option Exercise0.004,426047,763Jun 18 11:27 AM
Owens Gary MPresident and CEOJun 16 '25Sale97.121,939188,31245,824Jun 18 11:27 AM
Archbold Brian DavidSVP OperationsJun 15 '25Option Exercise0.001,03001,030Jun 18 11:13 AM
Archbold Brian DavidSVP OperationsJun 16 '25Sale97.1247245,840558Jun 18 11:13 AM
Sakys JohnCFOJun 15 '25Option Exercise0.00793012,839Jun 18 10:59 AM
Sakys JohnCFOJun 16 '25Sale97.1264262,35012,865Jun 18 10:59 AM
Archbold Brian DavidOfficerJun 16 '25Proposed Sale97.1247245,840Jun 16 03:49 PM
Owens Gary MOfficerJun 16 '25Proposed Sale97.121,939188,311Jun 16 03:47 PM
Sakys JohnOfficerJun 16 '25Proposed Sale97.1264262,350Jun 16 03:40 PM